Next Article in Journal
Anticoagulant and Antithrombotic Properties of Three Structurally Correlated Sea Urchin Sulfated Glycans and Their Low-Molecular-Weight Derivatives
Next Article in Special Issue
Metabolic and Biosynthetic Diversity in Marine Myxobacteria
Previous Article in Journal
Chemical Reactivity Properties, pKa Values, AGEs Inhibitor Abilities and Bioactivity Scores of the Mirabamides A–H Peptides of Marine Origin Studied by Means of Conceptual DFT
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessReview
Mar. Drugs 2018, 16(9), 303; https://doi.org/10.3390/md16090303

Future Directions of Marine Myxobacterial Natural Product Discovery Inferred from Metagenomics

1
Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)—Helmholtz Centre for Infection Research (HZI), Campus E8 1, 66123 Saarbrücken, Germany
2
German Center for Infection Research (DZIF), Partner site Hannover-Braunschweig, Inhoffenstrasse 7, 38124 Braunschweig, Germany
3
Xenobe Research Institute, P.O. Box 3052, San Diego, CA 92163-1052, USA
4
Department of Pharmacy, Saarland University, Campus E8 1, 66123 Saarbrücken, Germany
*
Author to whom correspondence should be addressed.
Received: 31 July 2018 / Revised: 18 August 2018 / Accepted: 23 August 2018 / Published: 29 August 2018
(This article belongs to the Special Issue Marine Myxobacteria: Sea Secrets from the Slime)
Full-Text   |   PDF [2083 KB, uploaded 29 August 2018]   |  

Abstract

Over the last two decades, halophilic (organisms that thrive at high salt concentrations) and halotolerant (organisms that have adapted to high salt concentrations) myxobacteria emerged as an important source of structurally diverse secondary metabolites from the marine environment. This review explores the advance of metagenomics analysis and 16S rRNA gene phylogeny of the cultured and uncultured myxobacteria from marine and other salt-environments up to July 2018. The diversity of novel groups of myxobacteria in these environments appears unprecedented, especially in the Sorangiineae and Nannocystineae suborders. The Sandaracinaceae related clade in the Sorangiineae suborder seems more widely distributed compared to the exclusively marine myxobacterial cluster. Some of the previously identified clones from metagenomic studies were found to be related to the Nannocystineae suborder. This understanding provides the foundation for a vital, unexplored resource. Understanding the conditions required to cultivate these yet “uncultured” myxobacteria in the laboratory, while a key next step, offers a significant potential to further expand access to diverse secondary metabolites. View Full-Text
Keywords: marine myxobacteria; metagenomics; uncultured; halophilic organisms; anaerobic; 16S rRNA; Sorangiineae; Nannocystineae; Sandaracinaceae related clades; marine myxobacterial clusters marine myxobacteria; metagenomics; uncultured; halophilic organisms; anaerobic; 16S rRNA; Sorangiineae; Nannocystineae; Sandaracinaceae related clades; marine myxobacterial clusters
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Garcia, R.; La Clair, J.J.; Müller, R. Future Directions of Marine Myxobacterial Natural Product Discovery Inferred from Metagenomics. Mar. Drugs 2018, 16, 303.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top